Peptide Aggregation and Purity: How Size-Exclusion Chromatography (SEC-HPLC) Detects Dimers and Oligomers

Educational information for a laboratory audience. Not medical advice, not a recommendation for human use. Peak Labs products are for laboratory research use only.

Purity figures on a certificate of analysis usually describe how much of a sample is the intended peptide versus truncated or unrelated impurities. They rarely say anything about whether that peptide is present as a single, well-behaved monomer or whether a fraction of it has clumped into dimers, trimers, or larger aggregates. For laboratories working with reconstituted peptide solutions, aggregation state is a separate and important quality dimension, and size-exclusion chromatography is the standard method used to characterize it.

What Aggregation Is and Why It Matters for Peptide Research

Aggregation occurs when individual peptide molecules associate with one another, forming soluble oligomers or, in more advanced cases, insoluble particulates. It can arise during synthesis, during lyophilisation, or after reconstitution, and it is influenced by concentration, pH, temperature, and the intrinsic sequence of the peptide itself. Hydrophobic stretches and certain secondary structural motifs make some peptides considerably more prone to self-association than others.

For a laboratory, aggregation state matters because it affects reproducibility. A sample that reads as high purity by reverse-phase HPLC can still contain a meaningful aggregate fraction, since reverse-phase methods separate primarily by hydrophobicity rather than by molecular size. Two vials with identical reported purity can therefore behave differently in downstream assays if their aggregation profiles differ.

Aggregation vs Degradation

Aggregation should be distinguished from chemical degradation. Degradation changes the covalent structure of the peptide, for example through oxidation, deamidation, or hydrolysis, and is typically detected by mass spectrometry as documented in our overview of HPLC versus mass spectrometry for peptide verification. Aggregation, by contrast, is a physical association of otherwise intact molecules. A peptide can be chemically pure and still aggregate, and a degraded peptide fragment can still aggregate independently. The two phenomena are tracked with different analytical tools and are not interchangeable indicators.

How Size-Exclusion Chromatography Works

Size-exclusion chromatography, commonly abbreviated SEC or referred to as SEC-HPLC when run on high-performance liquid chromatography instrumentation, separates molecules according to hydrodynamic size rather than charge or hydrophobicity. The stationary phase is a porous resin. Smaller molecules diffuse into the pores and take a longer, more circuitous path through the column, while larger species, including dimers and oligomers, are excluded from the pores and elute earlier. The result is a chromatogram in which elution time correlates inversely with apparent molecular size.

Column Selection and Mobile Phase Considerations

Column pore size is chosen to match the expected molecular weight range of the peptide and its potential aggregates, since a column optimized for large proteins may not adequately resolve small peptide oligomers, and vice versa. Mobile phase composition, including ionic strength and pH, is also carefully controlled, because a poorly buffered mobile phase can itself induce non-specific aggregation or, conversely, mask real aggregation by disrupting weak non-covalent associations during the run. This is a laboratory analytical parameter and has no bearing on how a compound would be handled outside of a testing context.

Reading an SEC-HPLC Chromatogram

An SEC-HPLC trace is typically read as a series of peaks plotted against elution time or retention volume. Analysts compare peak positions to a calibration curve built from reference standards of known molecular weight, allowing an approximate size to be assigned to each peak.

Monomer Peak, Dimers, and Higher-Order Oligomers

The dominant peak in a well-behaved sample corresponds to the monomer, the intact single-chain peptide at its expected molecular weight. Smaller peaks eluting earlier represent dimers, trimers, or higher-order oligomers. Percent monomer, calculated as the area of the monomer peak divided by the total peak area, is the figure most often cited to describe aggregation state, in the same way that HPLC area percent is used to describe chemical purity. A laboratory evaluating a batch will generally want to see the monomer percentage alongside, not instead of, the standard purity figure.

SEC-HPLC in Context: Complementary, Not Redundant, to Other Methods

SEC-HPLC does not replace reverse-phase HPLC or mass spectrometry, it complements them. Reverse-phase HPLC and mass spectrometry, discussed in more depth in our guide to reading a peptide certificate of analysis, address chemical identity and purity. SEC-HPLC addresses physical size distribution. A complete analytical picture of a batch draws on all three: identity confirmation, chemical purity, and aggregation state, each answering a distinct question about the sample.

Factors That Influence Aggregation in Storage and Handling

Because aggregation is concentration- and condition-dependent, how a peptide is stored and handled in the laboratory can influence the aggregation state observed at the point of use. Repeated freeze-thaw cycles, prolonged exposure to elevated temperature, and mechanical agitation are commonly cited contributors to increased oligomer formation over time. This is why laboratories that work with reconstituted peptide solutions often adopt single-use aliquoting practices and document handling conditions carefully, treating aggregation risk as a variable to be controlled and recorded rather than assumed away. Documentation practices of this kind are part of good laboratory record-keeping generally, alongside batch and lot traceability.

What to Look for on a Certificate of Analysis

Not every certificate of analysis includes SEC-HPLC data, since it is an additional test beyond the identity and purity assays that are more universally reported. When it is present, it is usually expressed as percent monomer or percent aggregate. Our certificate of analysis reference page outlines the standard elements a COA should contain and how they relate to one another. Laboratories that require aggregation data for a specific application should confirm with the supplier, before ordering, whether SEC-HPLC results are available for the batch in question or can be requested.

Questions to Ask a Supplier About Aggregation Testing

Researchers evaluating a supplier's analytical capabilities can reasonably ask whether SEC-HPLC or an equivalent size-based method is run routinely or only on request, what reference standards are used for molecular weight calibration, and whether raw chromatograms are available alongside summary percentages. A supplier that can answer these questions with specificity, rather than generic assurances, is generally easier to evaluate on documentation quality. Peak Labs maintains a general catalogue of research peptides alongside COA documentation for reference.

Sources and further reading

• USP: United States Pharmacopeia
• IUPAC: International Union of Pure and Applied Chemistry
• PubChem: National Center for Biotechnology Information
• NIST Chemistry WebBook

Research use only. Peak Labs products are supplied strictly for in-vitro laboratory research. They are not medicines or supplements, are not for human or veterinary use, and are not intended to diagnose, treat, cure, or prevent any condition.